NEWS
General Information
The Innovative Health Initiative (IHI) is a partnership between the European Union and industry associations representing the sectors involved in healthcare, namely COCIR (medical imaging, radiotherapy, health ICT and electromedical industries); EFPIA, including Vaccines Europe (pharmaceutical industry and vaccine industry); EuropaBio (biotechnology industry); and MedTech Europe (medical technology industry).
By supporting projects that bring together these industries as well as universities, small and medium-sized enterprises (SMEs), patients, regulators and others, we aim to pioneer a new, more integrated approach to health research. Our approach moves the focus from disease care to health care, starting with disease prevention, and covering diagnostics, (personalised) treatments, and disease management. At every step, products and services from different sectors would be seamlessly integrated, making it easier than ever for patients and their clinicians to monitor and manage their health.
IHI's objectives:
IHI’s objectives are set out in the legislation creating IHI.
General objectives are to:
turn health research and innovation into real benefits for patients and society;
deliver safe, effective health innovations that cover the entire spectrum of care – from prevention to diagnosis and treatment – particularly in areas where there is an unmet public health need;
make Europe’s health industries globally competitive.
The legislation also includes the following specific objectives, which are described in more detail in the Strategic Research and Innovation Agenda (SRIA).
Improve our understanding of the factors that affect our health and the development and treatment of certain diseases.
Integrate fragmented health research and innovation efforts by bringing together health industry sectors and other stakeholders. This will enable the development of tools, data, platforms, technologies and processes that will in turn facilitate the prevention, diagnosis, treatment and management of diseases, especially in areas where there is an unmet public health need.
Demonstrate the feasibility of integrated healthcare solutions that draw on various technologies from different sectors and address the needs of the people who will use them, such as patients and healthcare professionals.
Make better of opportunities to gather health data and use it in research and care, all while respecting relevant privacy legislation.
Develop ways of assessing the value of innovative, integrated health care solutions to patients, carers, healthcare professionals and organisations, and other stakeholders.
On the policy front, we expect IHI’s projects to contribute to EU policies, most notably Horizon Europe (of which IHI is a part), as well as Europe's Beating Cancer Plan, the new Industrial Strategy for Europe, the Pharmaceutical Strategy for Europe and the European Health Data Space. In addition, IHI contributes to the United Nations Sustainable Development Goal (SDG) 3 on ensuring healthy lives and promoting well-being for all at all ages.
IHI call 9 – a single-stage, applicant driven call
IHI call 9 will be a single-stage, applicant-driven call with five topics aligned with the five specific objectives set out in the IHI Strategic Research and Innovation Agenda (SRIA). For this call, we want applicants to explore the SRIA and identify untapped opportunities that could be transformed into public-private projects through IHI.
Proposals will still have to adhere to the philosophy of IHI. In other words, they will have to: address an unmet public health need; require a large-scale, ambitious, cross-sector, public-private partnership; have clearly-described impacts on society, the economy and science; take account of the pre-competitive nature of IHI projects.
New! Download the draft call 9 text
New! Read our FAQs on IHI call 9
Read our news storyabout the call
Watch the recording and view the slides from our online info session on 10 October, which covered the scope of IHI call 9 and how to get the most out of our brokerage platform and event.
Register for our brokerage platform and event. The event will be held in Brussels on 12-13 November, and online on 14 November. The platform will remain open until the call deadline.
IHI call 10 – a standard, two-stage call
The topics under consideration for inclusion in this call are:
Digital label: one source of comprehensive information for medical technology products
Safeguarding innovation in secondary use of health data in the European Health Data Space (EHDS)
Call Information
IHI call 8 (Call ID: HORIZON-JU-IHI-2024-08-two-stage | Action type: RIA - Research and Innovation Actions | Call type: Two-stage)
IHI call 8 is a two-stage call with topics on cardiovascular disease, osteoarthritis, regulatory sandboxes, and patient-centred endpoints
Topics
- Topic 1: A city-based approach to reducing cardiovascular mortality in Europe
- Topic 2: Novel endpoints for osteoarthritis (OA) by applying big data analytics
- Topic 3: Modelling regulatory sandbox mechanisms and enabling their deployment to support breakthrough innovation
- Topic 4: Patient-centred clinical-study endpoints derived using digital health technologies
For full details of the topics, including the budget breakdown, read the call text.
All documents relating to the call can be found via the Funding and Tenders Portal and the IHI call documents page (https://www.ihi.europa.eu/apply-funding/call-documents).
Key dates and deadlines:
Call launch: 25 June 2024
Short proposal submission deadline: 10 October 2024 at 17:00 Brussels time
Full proposal submission deadline: 23 April 2025 at 17:00 Brussels time
Other Informations
https://www.ihi.europa.eu/apply-funding/open-calls
